GLP-1 Therapies Possible Treatment for Bardet-Biedl Syndrome (IMAGE)
Caption
The GLP-1 receptor agonists class of drugs is a promising therapeutic for managing the metabolic complications associated with Bardet-Biedl Syndrome
Credit
Arashdeep Singh, Monell Chemical Senses Center. The image was generated in Biorender.
Usage Restrictions
No restrictions
License
Original content